These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4638209)

  • 21. Incorporation of uridine into ribonucleic acid in rat brain slices after 9 -tetrahydrocannabinol and cannabis.
    Roberge M; Witschi H
    Toxicol Appl Pharmacol; 1972 Nov; 23(3):455-8. PubMed ID: 5085458
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of delta9-tetrahydrocannabinol on rat liver microsomal lipid peroxidation.
    Mitra G; Poddar MK; Ghosh JJ
    Toxicol Appl Pharmacol; 1975 Dec; 34(3):525-8. PubMed ID: 1872
    [No Abstract]   [Full Text] [Related]  

  • 23. Endocrine effects of chronic intraventricular administration of delta9-tetrahydrocannabinol to prepuberal and adult male rats.
    Collu R
    Life Sci; 1976 Jan; 18(2):223-30. PubMed ID: 1256238
    [No Abstract]   [Full Text] [Related]  

  • 24. Acute antiepileptic effects of 9-tetrahydrocannabinol in rats with kindled seizures.
    Corcoran ME; McCaughran JA; Wada JA
    Exp Neurol; 1973 Aug; 40(2):471-83. PubMed ID: 4354188
    [No Abstract]   [Full Text] [Related]  

  • 25. Differential neurochemistry and temporal pattern in rats treated orally with delta9-tetrahydrocannabinol for periods up to six months.
    Luthra UL; Rosenkrantz H; Heyman IA; Braude MC
    Toxicol Appl Pharmacol; 1975 May; 32(2):418-31. PubMed ID: 1171540
    [No Abstract]   [Full Text] [Related]  

  • 26. [In vitro inhibition of the blastogenesis of T lymphocytes by delta 9 tetrahydrocannabinol].
    Nahas G; Armand JP; Hsu J
    C R Acad Hebd Seances Acad Sci D; 1974 Jan; 278(5):679-80. PubMed ID: 4211468
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of cannabis extract, 9 -tetrahydrocannabinol and lysergic acid diethylamide on rat liver enzymes.
    Poddar MK; Ghosh JJ
    Biochem Pharmacol; 1972 Dec; 21(24):3301-3. PubMed ID: 4405370
    [No Abstract]   [Full Text] [Related]  

  • 28. Lysis of rat liver lysosomes in vitro by delta9-tetrahydrocannabinol.
    Britton RS; Mellors A
    Biochem Pharmacol; 1974 Apr; 23(8):1342-4. PubMed ID: 4824779
    [No Abstract]   [Full Text] [Related]  

  • 29. Epileptiform seizures in domestic fowl. V. The anticonvulsant activity of delta9-tetrahydrocannabinol.
    Johnson DD; McNeill JR; Crawford RD; Wilcox WC
    Can J Physiol Pharmacol; 1975 Dec; 53(6):1007-13. PubMed ID: 1222370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The distribution of delta1-tetrahydrocannabinol and 7-hydroxy-delta-tetrahydrocannabinol in the mouse brain after intraventricular injection.
    Gill EW; Lawrence DK
    J Pharm Pharmacol; 1973 Dec; 25(12):948-52. PubMed ID: 4150297
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of delta9-tetrahydrocannabinol on neurotransmitter accumulation and release mechanisms in rat forebrain synaptosomes.
    Johnson KM; Ho BT; Dewey WL
    Life Sci; 1976 Aug; 19(3):347-56. PubMed ID: 957874
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of delta-9-tetrahydrocannabinol on social behaviour in the laboratory mouse and rat.
    Cutler MG; Mackintosh JH
    Psychopharmacologia; 1975 Nov; 44(3):287-9. PubMed ID: 1239783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo and in vitro effects of delta9-tetrahydrocannabinol on rats liver microsomal drug-metabolizing enzymes.
    Mitra G; Poddar MK; Ghosh JJ
    Toxicol Appl Pharmacol; 1976 Mar; 35(3):523-30. PubMed ID: 1265765
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of delta1-tetrahydrocannabinol on the release of (3H-(-)-noradrenaline from the isolated vas deferens of the rat.
    Graham JD; Lewis MJ; Li DM
    Br J Pharmacol; 1974 Oct; 52(2):233-6. PubMed ID: 4451818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delta9-tetrahydrocannabinol methamphetamine interaction in the rabbit.
    Consroe PF; Jones BC; Akins F
    Neuropharmacology; 1975; 14(5-6):377-83. PubMed ID: 1171388
    [No Abstract]   [Full Text] [Related]  

  • 36. delta9-tetrahydrocannabinol alters flow of blood to subcortical areas of the conscious rat brain.
    Goldman H; Dagirmanjian R; Drew WG; Murphy S
    Life Sci; 1975 Aug; 17(3):477-82. PubMed ID: 1160517
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of mescaline, [delta9]-tetrahydrocannabinol and pentobarbital on the auditory evoked responses in the cat.
    Guha D; Pradhan SN
    Neuropharmacology; 1974 Aug; 13(8):755-62. PubMed ID: 4444761
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of tetrahydrocannabinol on hippocampal evoked afterdischarges in cats.
    Feeney DM; Wagner HR; McNamara MC; Weiss G
    Exp Neurol; 1973 Nov; 41(2):357-65. PubMed ID: 4746199
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of 1-delta9-tetrahydrocannabinol, dl-amphetamine and pentobarbital on oxygen consumption by mouse brain and heart homogenates.
    Dembert ML; Harclerode J
    Biochem Pharmacol; 1974 Mar; 23(5):947-56. PubMed ID: 4458679
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of delta1-tetrahydrocannabinol on the uptake of [3H]-(minus)-noradrenaline by the isolated perfused heart of the rat.
    Graham JD; Lewis MJ; Li DM
    Br J Pharmacol; 1974 Jul; 51(3):465-6. PubMed ID: 4451760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.